1,720,982 research outputs found

    Clinical psychology for cardiac disease

    No full text
    From its very beginning, modern scientific psychology has dealt with issues regarding mind-body, health-disease relationships; in particular, clinical psychology, in its various applications, has tried to provide a structure to psychological concepts tied to organic disease. Clinical psychology is described as the “area of psychology whose objectives are the explanation, understanding, interpretation and reorganization of dysfunctional or pathological mental processes, both individual and interpersonal, together with their behavioral and psychobiological correlates” [2]. Clinical psychology is characterized by a variety of models, methods, theories and techniques, each of which has its own historical reason. Its core and indispensable common denominator is clinical practice, be it intended for individuals, groups or collectives [3]. Among its areas of application we can include psychosomatics, health psychology and hospital psychology, where clinical psychology offers a relevant and coherent scientific, professional and training frame through contributions aimed at health maintenance and promotion, identification of etiological and diagnostic correlates, analysis and improvement of health care, and enhancement of public health [4]

    Una psicologia clinica per la malattia cardiaca

    No full text
    La moderna psicologia scientifica si è sin dagli inizi occupata di problematiche riguardanti il legame tra salute/malattia del corpo e salute/malattia della mente. In particolare la psicologia clinica ha cercato, nelle sue diverse applicazioni, di dare una sempre maggiore sistematicità ai concetti psicologici collegati alla malattia organica. La psicologia clinica viene descritta come:“un settore della psicologia i cui obbiettivi sono la spiegazione, la comprensione, l’interpretazione e la riorganizzazione dei processi mentali disfunzionali o patologici, individuali e interpersonali, unitamente ai loro correlati comportamentali e psicobiologici”

    Improving partnership to improve health outcomes

    No full text
    The word prostate cancer (PCa) can evoke very different meanings and scenarios in the actors that are involved in the clinical consultation. For the doctor, the word can refer to abnormalities of the structure and function of body organs and systems that he is called to restore. For the patient, the same word can mean a strange feeling of powerlessness and anxiety or something to fight. During the clinical visit, the attention – both of patients and doctors – is on the ill part of the body. The main expected work of the doctor is to define the optimal treatment, and the main one of the patient is to adhere to this optimal treatment. However, this medical vision does not reflect entirely what really happens during the clinical consultation. Scholars and clinicians are more and more recognizing that curing the disease is not always only a medical matter. Indeed, what patients feel and experience concerning their disease and the relationship they establish with the disease can make the difference in the disease course and substantially change the clinical pathway. Patients might consequently choose not to adhere to treatments, or conversely can be highly engaged in healthpromoting behaviours and reduce the burden of the disease. The question now is how can patients and doctors become partners in navigating the illness journey

    Clinical and psychological telemonitoring and telecare of high risk heart failure patients

    No full text
    We conducted a trial of telemonitoring and telecare for patients with chronic heart failure leaving hospital after being treated for clinical instability. Eighty patients were randomized before hospital discharge to a usual care group (n 1⁄4 40: follow-up at the outpatient clinic) or to an integrated management group (n 1⁄4 40: patients learned to use a handheld PDA and kept in touch daily with the monitoring centre). At enrolment, the groups were similar for all clinical variables. At one-year follow-up, integrated management patients showed better adherence, reduced anxiety and depression, and lower NYHA class and plasma levels of BNP with respect to the usual care patients (e.g. NYHA class 2.1 vs 2.4, P < 0.02). Mortality and hospital re-admissions for congestive heart failure were also reduced in integrated management patients (P < 0.05). Integrated management was more expensive than usual care, although the cost of adverse events was 42% lower. In heart failure patients at high risk of relapse, the regular acquisition of simple clinical information and the possibility for the patient to contact the clinical staff improved drug titration, produced better psychological status and quality of life, and reduced hospitalizations for heart failure

    Prostate cancer patients on active surveillance: is physical activity associated with health-related quality of life?

    No full text
    The benefits of physical activity (PA), even of low intensity, on disease progression, urinary symptoms, psychological wellbeing, and health-related quality of life (HRQoL) of prostate cancer (PCa) patients have been documented by several studies (Richman 2011; Chipperfield 2014; Thorsen 2008). To our knowledge, there are no studies investigating the effects of PA on HRQoL among PCa patients in Active Surveillance (AS). The present research aimed to study the relationship between the level of PA performed by patients in AS and their HRQoL

    Clinical and psychological telemonitoring and telecare of high risk heart failure patients.

    No full text
    We conducted a trial of telemonitoring and telecare for patients with chronic heart failure leaving hospital after being treated for clinical instability. Eighty patients were randomized before hospital discharge to a usual care group (n=40: follow-up at the outpatient clinic) or to an integrated management group (n=40: patients learned to use a handheld PDA and kept in touch daily with the monitoring centre). At enrolment, the groups were similar for all clinical variables. At one-year follow-up, integrated management patients showed better adherence, reduced anxiety and depression, and lower NYHA class and plasma levels of BNP with respect to the usual care patients (e.g. NYHA class 2.1 vs 2.4, P<0.02). Mortality and hospital re-admissions for congestive heart failure were also reduced in integrated management patients (P<0.05). Integrated management was more expensive than usual care, although the cost of adverse events was 42% lower. In heart failure patients at high risk of relapse, the regular acquisition of simple clinical information and the possibility for the patient to contact the clinical staff improved drug titration, produced better psychological status and quality of life, and reduced hospitalizations for heart failure
    corecore